Stocks and InvestingStocks and Investing
Mon, October 30, 2017
Fri, October 27, 2017
Thu, October 26, 2017

Matthew Harrison Maintained (AMGN) at Buy with Decreased Target to $193 on, Oct 26th, 2017


Published on 2024-10-26 00:00:22 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Amgen Inc." (AMGN) at Buy with Decreased Target from $196 to $193 on, Oct 26th, 2017.

Matthew has made no other calls on AMGN in the last 4 months.



There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 3 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $190 on, Friday, October 13th, 2017
  • Michael Yee of "RBC Capital" Initiated at Hold and Held Target at $192 on, Friday, September 15th, 2017
  • Carter Gould of "UBS" Maintained at Hold with Increased Target to $185 on, Wednesday, July 26th, 2017


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $186 on, Friday, September 29th, 2017
  • David Toung of "Argus Research" Maintained at Strong Buy with Increased Target to $195 on, Thursday, July 27th, 2017